Pulmonary Arterial Hypertension

Week in Review: At-home flu testing, asymptomatic monkeypox, telediagnostic accuracy, and more

Dear LabPulse.com member,

September 7, 2022

Elevated cfDNA levels linked to severity of PAH

The new blood test measures DNA fragments shed by damaged cells; according to the NIH, the test could also be used to predict survivability.

August 31, 2022

Clinical trial planned for COVID-19 rapid breath test

The investigational BreathTest-1000 mass spectrometer is being positioned as a noninvasive, self-administered test of breath samples for various COVID-19 strains. The developers envisage that relative to the gold standard for COVID-19 detection, polymerase chain reaction (PCR) tests, their product would be a lower-cost, more convenient option suitable for wide distribution.

October 20, 2020

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Quest Diagnostics offers suite of services for transplant patients and living donors

Rapid nirmatrelvir treatment in study reduced long-COVID risk